🏛️ Verified NIH Record • Updated 2026-05-11
Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301) (NCT06846515)
A Phase 3 Randomized, Double-blind, Multi-center, Placebo-controlled Study to Evaluate the Efficacy and Safety of AR882 in Participants With Gout
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic Sponsor: Arthrosi Therapeutics
🩺 Plain-English Summary (8th-Grade Level)
This study will assess the serum uric acid lowering effect and safety of AR882 in gout patients at two doses compared to placebo over 12 months
Who can join: Review the eligibility criteria below.
Location: Arthrosi Investigative Site (620) — Birmingham, Alabama
Age range: 18 Years to 85 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (83 Sites)
Showing the first 25 of 83 sites.
- Arthrosi Investigative Site (620) — Birmingham, Alabama
- Arthrosi Investigative Site (616) — Huntsville, Alabama
- Arthrosi Investigative Site (680) — Peoria, Arizona
- Arthrosi Investigative Site (640) — Phoenix, Arizona
- Arthrosi Investigative Site (617) — Little Rock, Arkansas
- Arthrosi Investigative Site (614) — Garden Grove, California
- Arthrosi Investigative Site (618) — La Mesa, California
- Arthrosi Investigative Site (687) — La Mesa, California
- Arthrosi Investigative Site (655) — La Palma, California
- Arthrosi Investigative Site (632) — Lincoln, California
- Arthrosi Investigative Site (605) — Lomita, California
- Arthrosi Investigative Site (675) — Long Beach, California
- Arthrosi Investigative Site (603) — Santa Monica, California
- Arthrosi Investigative Site (672) — Tarzana, California
- Arthrosi Investigative Site (656) — Thousand Oaks, California
- Arthrosi Investigative Site (660) — Aurora, Colorado
- Arthrosi Investigative Site (669) — Colorado Springs, Colorado
- Arthrosi Investigative Site (612) — Fort Collins, Colorado
- Arthrosi Investigative Site (665) — Cooper City, Florida
- Arthrosi Investigative Site (613) — Jupiter, Florida
- Arthrosi Investigative Site (611) — Miami, Florida
- Arthrosi Investigative Site (644) — Miami, Florida
- Arthrosi Investigative Site (694) — Palmetto Bay, Florida
- Arthrosi Investigative Site (615) — Sanford, Florida
- Arthrosi Investigative Site (600) — Tampa, Florida
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Gout
- Assessing the Role of the NLRP3 Inflammasome in Intercritical Gout — Beverly Hills, California
- Gout in the ED and Improving Research Participation — Birmingham, Alabama
- Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients — Margate, Florida
- Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001. — Sacramento, California
- PK and Safety Evaluation Study of SAP-001 in Adult Subjects With Normal and Impaired Renal Function — Tampa, Florida
Explore by condition: All Gout clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.